Kite Pharma, Inc.;United States of America, as represented by the Secretary, Department of Health and Human Services
发明人:
Adrian BOT,Jeffrey S. WIEZOREK,William GO,Rajul JAIN,James N. KOCHENDERFER,Steven A. ROSENBERG
申请号：
US15950042
公开号：
US20180369283A1
申请日:
2018.04.10
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
